Cash And Equivalent تغییر دادن تاریخ
Agios Pharmaceuticals USD 88.2M 23.87M 2023-12
ALKERMES USD 647.71M 18.08M 2023-09
Alterity Therapeutics Limited AUD 15.77M 9.56M 2023-06
Amgen USD 10.94B 23.8B 2023-12
Baxter International USD 3.19B 2.59B 2023-12
BioCryst Pharmaceuticals USD 397.59M 251.38M 2023-09
Biogen USD 1.05B 1.24B 2023-12
Bluebird Bio USD 165.35M 7.52M 2023-09
Bristol-Myers Squibb USD 11.46B 3.95B 2023-12
Cara Therapeutics USD 62.88M 4.63M 2023-09
Eisai JPY 281.45B 12.15B 2023-09
Eli Lilly USD 2.38B 313.7M 2023-09
Esperion Therapeutics USD 114.83M 23.64M 2023-09
Exelixis USD 396.86M 67.62M 2023-09
Gilead Sciences USD 8.43B 2.72B 2023-12
GlaxoSmithKline GBP 3.18B 37M 2023-09
Grifols EUR 484.23M 39.13M 2023-09
Halozyme Therapeutics USD 118.37M 155.86M 2023-12
Incyte USD 3.21B 13.85M 2023-12
Ionis Pharmaceuticals USD 399.27M 47.21M 2023-12
Ironwood Pharmaceuticals USD 92.15M 18.01M 2023-12
Merck USD 8.6B 2.94B 2023-09
Nektar Therapeutics USD 64.92M 14.19M 2023-09
Neurocrine Biosciences USD 293.7M 133.5M 2023-09
Pfizer USD 3.15B 516M 2023-09
Roche Holding CHF 3.72B 1.27B 2023-06
Sarepta Therapeutics USD 541.93M 310M 2023-09
Takeda JPY 318.05B 1.67B 2023-09
Teva Pharmaceutical Industries USD 2.25B 420M 2023-09
Xencor USD 53.79M 1.06M 2023-12



Nektar Therapeutics پول نقد و معادل - ارزش های فعلی، داده های تاریخی، پیش بینی، آمار، نمودار و تقویم اقتصادی - Mar 2024.